Source: Annual Congress 2004 - Immunology in pulmonary diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chorostowska-Wynimko, D. Radomska, D. Gorecka, E. Skopinska-Rozewska (Warsaw, Poland). OSA patients sera are characterized by the decreased angiogenic activity. Eur Respir J 2004; 24: Suppl. 48, 2231

Member's Comments

No comment yet.

Related content which might interest you: TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Circulating inflammatory proteins and red blood cells antioxidant activity in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 537s Year: 2003 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021 Destructive-cytolytic and peroxidase activity of bronchial granulocytes in asthma patients with different levels of disease control Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7 Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Is OSA an important risk factor for metabolic dysregulation in obese COPD patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 CPAP decreases elevated plasma levels of soluble tumor necrosis factor-α receptor 1 in OSAS patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008